nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—ORM1—Quinidine—malaria	0.167	0.247	CbGbCtD
Canagliflozin—ABCC2—Quinidine—malaria	0.113	0.167	CbGbCtD
Canagliflozin—CYP3A4—Clindamycin—malaria	0.0849	0.125	CbGbCtD
Canagliflozin—CYP3A4—Sulfadiazine—malaria	0.0487	0.0721	CbGbCtD
Canagliflozin—ABCB1—Quinine—malaria	0.0419	0.062	CbGbCtD
Canagliflozin—CYP3A4—Artemether—malaria	0.0414	0.0613	CbGbCtD
Canagliflozin—CYP3A4—Proguanil—malaria	0.039	0.0576	CbGbCtD
Canagliflozin—CYP3A4—Doxycycline—malaria	0.0369	0.0546	CbGbCtD
Canagliflozin—ABCB1—Quinidine—malaria	0.0368	0.0545	CbGbCtD
Canagliflozin—CYP3A4—Quinine—malaria	0.0251	0.0371	CbGbCtD
Canagliflozin—Vulvitis—Clindamycin—malaria	0.0232	0.12	CcSEcCtD
Canagliflozin—CYP3A4—Quinidine—malaria	0.0221	0.0326	CbGbCtD
Canagliflozin—CYP3A4—Dapsone—malaria	0.019	0.0281	CbGbCtD
Canagliflozin—SLC5A2—blood plasma—malaria	0.0185	0.194	CbGeAlD
Canagliflozin—Vulvovaginitis—Clindamycin—malaria	0.0125	0.0648	CcSEcCtD
Canagliflozin—ORM1—saliva—malaria	0.0107	0.112	CbGeAlD
Canagliflozin—SLC5A2—kidney—malaria	0.00838	0.0877	CbGeAlD
Canagliflozin—Diuresis—Sulfadiazine—malaria	0.00836	0.0434	CcSEcCtD
Canagliflozin—SLC5A2—blood—malaria	0.00677	0.0709	CbGeAlD
Canagliflozin—Sunburn—Clindamycin—malaria	0.00639	0.0332	CcSEcCtD
Canagliflozin—SLC5A1—kidney—malaria	0.00635	0.0665	CbGeAlD
Canagliflozin—SLC5A1—digestive system—malaria	0.00539	0.0564	CbGeAlD
Canagliflozin—Prurigo—Clindamycin—malaria	0.00418	0.0217	CcSEcCtD
Canagliflozin—UGT1A9—kidney—malaria	0.004	0.0418	CbGeAlD
Canagliflozin—UGT2B4—liver—malaria	0.0037	0.0387	CbGeAlD
Canagliflozin—Vulvovaginal candidiasis—Clindamycin—malaria	0.00367	0.0191	CcSEcCtD
Canagliflozin—Vulvovaginal mycotic infection—Clindamycin—malaria	0.00353	0.0183	CcSEcCtD
Canagliflozin—UGT1A9—digestive system—malaria	0.00339	0.0355	CbGeAlD
Canagliflozin—ORM1—hematopoietic system—malaria	0.00257	0.0269	CbGeAlD
Canagliflozin—UGT1A9—liver—malaria	0.00253	0.0264	CbGeAlD
Canagliflozin—Rash erythematous—Clindamycin—malaria	0.00252	0.0131	CcSEcCtD
Canagliflozin—Rash pustular—Clindamycin—malaria	0.00242	0.0126	CcSEcCtD
Canagliflozin—Polyuria—Sulfadiazine—malaria	0.00214	0.0111	CcSEcCtD
Canagliflozin—CYP3A4—blood plasma—malaria	0.00194	0.0203	CbGeAlD
Canagliflozin—Hypoglycaemia—Sulfadiazine—malaria	0.00193	0.01	CcSEcCtD
Canagliflozin—Vaginal infection—Clindamycin—malaria	0.00182	0.00946	CcSEcCtD
Canagliflozin—Rash maculo-papular—Clindamycin—malaria	0.00175	0.00911	CcSEcCtD
Canagliflozin—ABCC2—kidney—malaria	0.00173	0.0181	CbGeAlD
Canagliflozin—Malnutrition—Proguanil—malaria	0.00171	0.00886	CcSEcCtD
Canagliflozin—Erythema—Proguanil—malaria	0.00171	0.00886	CcSEcCtD
Canagliflozin—ORM1—blood—malaria	0.0017	0.0178	CbGeAlD
Canagliflozin—ORM1—bone marrow—malaria	0.00164	0.0172	CbGeAlD
Canagliflozin—Pancreatitis—Sulfadiazine—malaria	0.00159	0.00827	CcSEcCtD
Canagliflozin—Photosensitivity—Quinidine—malaria	0.00157	0.00812	CcSEcCtD
Canagliflozin—Photosensitivity—Quinine—malaria	0.00157	0.00812	CcSEcCtD
Canagliflozin—ALB—Scavenging of heme from plasma—HBB—malaria	0.00154	0.0433	CbGpPWpGaD
Canagliflozin—Renal failure acute—Quinine—malaria	0.00149	0.00773	CcSEcCtD
Canagliflozin—Renal failure acute—Quinidine—malaria	0.00149	0.00773	CcSEcCtD
Canagliflozin—ABCC2—digestive system—malaria	0.00147	0.0153	CbGeAlD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00144	0.00749	CcSEcCtD
Canagliflozin—ALB—Scavenging of heme from plasma—HP—malaria	0.00142	0.0399	CbGpPWpGaD
Canagliflozin—Photosensitivity—Quinidine barbiturate—malaria	0.00141	0.00733	CcSEcCtD
Canagliflozin—Hypoglycaemia—Quinine—malaria	0.00141	0.00731	CcSEcCtD
Canagliflozin—Hypoglycaemia—Quinidine—malaria	0.00141	0.00731	CcSEcCtD
Canagliflozin—ABCC2—blood—malaria	0.0014	0.0146	CbGeAlD
Canagliflozin—ABCB1—blood plasma—malaria	0.00137	0.0144	CbGeAlD
Canagliflozin—Nervous system disorder—Proguanil—malaria	0.00137	0.00709	CcSEcCtD
Canagliflozin—Skin disorder—Proguanil—malaria	0.00135	0.00702	CcSEcCtD
Canagliflozin—Renal failure acute—Quinidine barbiturate—malaria	0.00134	0.00697	CcSEcCtD
Canagliflozin—ORM1—liver—malaria	0.00133	0.0139	CbGeAlD
Canagliflozin—Hypersensitivity—Pyrimethamine—malaria	0.00132	0.00684	CcSEcCtD
Canagliflozin—Thirst—Pentoxifylline—malaria	0.0013	0.00675	CcSEcCtD
Canagliflozin—Hypoglycaemia—Quinidine barbiturate—malaria	0.00127	0.0066	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Quinidine—malaria	0.00126	0.00652	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Quinine—malaria	0.00126	0.00652	CcSEcCtD
Canagliflozin—Breast disorder—Quinine—malaria	0.00124	0.00645	CcSEcCtD
Canagliflozin—Breast disorder—Quinidine—malaria	0.00124	0.00645	CcSEcCtD
Canagliflozin—Pancreatitis—Dapsone—malaria	0.00123	0.00637	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Proguanil—malaria	0.0012	0.00624	CcSEcCtD
Canagliflozin—SLC5A2—NRF2 pathway—G6PD—malaria	0.00118	0.0332	CbGpPWpGaD
Canagliflozin—SLC5A1—NRF2 pathway—G6PD—malaria	0.00118	0.0332	CbGpPWpGaD
Canagliflozin—ALB—liver—malaria	0.00117	0.0122	CbGeAlD
Canagliflozin—Photosensitivity reaction—Dapsone—malaria	0.00114	0.00593	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Proguanil—malaria	0.00114	0.00591	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Quinidine barbiturate—malaria	0.00113	0.00588	CcSEcCtD
Canagliflozin—Breast disorder—Quinidine barbiturate—malaria	0.00112	0.00582	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Clindamycin—malaria	0.00111	0.00574	CcSEcCtD
Canagliflozin—Abdominal pain—Proguanil—malaria	0.0011	0.00572	CcSEcCtD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC4A1—malaria	0.0011	0.0309	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC4A1—malaria	0.0011	0.0309	CbGpPWpGaD
Canagliflozin—ABCC2—liver—malaria	0.00109	0.0114	CbGeAlD
Canagliflozin—Photosensitivity reaction—Quinidine—malaria	0.00108	0.00563	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Quinine—malaria	0.00108	0.00563	CcSEcCtD
Canagliflozin—CYP3A4—hematopoietic system—malaria	0.00107	0.0112	CbGeAlD
Canagliflozin—Urinary tract infection—Clindamycin—malaria	0.00105	0.00545	CcSEcCtD
Canagliflozin—UGT2B4—Phase II conjugation—HPGDS—malaria	0.00104	0.0293	CbGpPWpGaD
Canagliflozin—Convulsion—Sulfadiazine—malaria	0.000982	0.0051	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Quinidine barbiturate—malaria	0.000979	0.00508	CcSEcCtD
Canagliflozin—Urinary tract disorder—Quinidine—malaria	0.000939	0.00487	CcSEcCtD
Canagliflozin—Urinary tract disorder—Quinine—malaria	0.000939	0.00487	CcSEcCtD
Canagliflozin—Urethral disorder—Quinidine—malaria	0.000932	0.00484	CcSEcCtD
Canagliflozin—Urethral disorder—Quinine—malaria	0.000932	0.00484	CcSEcCtD
Canagliflozin—ALB—brain—malaria	0.000925	0.00968	CbGeAlD
Canagliflozin—Rash—Proguanil—malaria	0.000879	0.00456	CcSEcCtD
Canagliflozin—Dermatitis—Proguanil—malaria	0.000878	0.00455	CcSEcCtD
Canagliflozin—CYP3A4—kidney—malaria	0.000878	0.00919	CbGeAlD
Canagliflozin—Erythema—Dapsone—malaria	0.000872	0.00453	CcSEcCtD
Canagliflozin—Urinary tract disorder—Quinidine barbiturate—malaria	0.000848	0.0044	CcSEcCtD
Canagliflozin—Erythema—Clindamycin—malaria	0.000844	0.00438	CcSEcCtD
Canagliflozin—Urethral disorder—Quinidine barbiturate—malaria	0.000841	0.00437	CcSEcCtD
Canagliflozin—SLC5A2—Carbohydrate metabolism—PKLR—malaria	0.000837	0.0235	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—PKLR—malaria	0.000837	0.0235	CbGpPWpGaD
Canagliflozin—Erythema—Quinidine—malaria	0.000828	0.0043	CcSEcCtD
Canagliflozin—Erythema—Quinine—malaria	0.000828	0.0043	CcSEcCtD
Canagliflozin—Malnutrition—Quinidine—malaria	0.000828	0.0043	CcSEcCtD
Canagliflozin—Malnutrition—Quinine—malaria	0.000828	0.0043	CcSEcCtD
Canagliflozin—Nausea—Proguanil—malaria	0.000828	0.00429	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Sulfadiazine—malaria	0.000799	0.00414	CcSEcCtD
Canagliflozin—ALB—HDL-mediated lipid transport—SCARB1—malaria	0.000763	0.0215	CbGpPWpGaD
Canagliflozin—ABCB1—hematopoietic system—malaria	0.000758	0.00794	CbGeAlD
Canagliflozin—Angioedema—Quinidine—malaria	0.000756	0.00393	CcSEcCtD
Canagliflozin—Angioedema—Quinine—malaria	0.000756	0.00393	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Sulfadiazine—malaria	0.000756	0.00392	CcSEcCtD
Canagliflozin—Erythema—Quinidine barbiturate—malaria	0.000747	0.00388	CcSEcCtD
Canagliflozin—Malnutrition—Quinidine barbiturate—malaria	0.000747	0.00388	CcSEcCtD
Canagliflozin—Erythema—Pentoxifylline—malaria	0.000746	0.00387	CcSEcCtD
Canagliflozin—SLC5A2—Carbohydrate metabolism—G6PD—malaria	0.000746	0.021	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—G6PD—malaria	0.000746	0.021	CbGpPWpGaD
Canagliflozin—CYP3A4—digestive system—malaria	0.000745	0.0078	CbGeAlD
Canagliflozin—Syncope—Quinidine—malaria	0.000742	0.00385	CcSEcCtD
Canagliflozin—Syncope—Quinine—malaria	0.000742	0.00385	CcSEcCtD
Canagliflozin—Urticaria—Sulfadiazine—malaria	0.000735	0.00381	CcSEcCtD
Canagliflozin—Abdominal pain—Sulfadiazine—malaria	0.000731	0.00379	CcSEcCtD
Canagliflozin—Loss of consciousness—Quinidine—malaria	0.000728	0.00378	CcSEcCtD
Canagliflozin—Loss of consciousness—Quinine—malaria	0.000728	0.00378	CcSEcCtD
Canagliflozin—Convulsion—Quinine—malaria	0.000717	0.00372	CcSEcCtD
Canagliflozin—Convulsion—Quinidine—malaria	0.000717	0.00372	CcSEcCtD
Canagliflozin—CYP3A4—blood—malaria	0.000709	0.00743	CbGeAlD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.0007	0.00363	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.0007	0.00363	CcSEcCtD
Canagliflozin—Angioedema—Quinidine barbiturate—malaria	0.000683	0.00354	CcSEcCtD
Canagliflozin—Angioedema—Pentoxifylline—malaria	0.000681	0.00354	CcSEcCtD
Canagliflozin—Hypersensitivity—Sulfadiazine—malaria	0.000681	0.00354	CcSEcCtD
Canagliflozin—Syncope—Quinidine barbiturate—malaria	0.00067	0.00348	CcSEcCtD
Canagliflozin—Shock—Quinine—malaria	0.000665	0.00345	CcSEcCtD
Canagliflozin—Shock—Quinidine—malaria	0.000665	0.00345	CcSEcCtD
Canagliflozin—Nervous system disorder—Quinidine—malaria	0.000663	0.00344	CcSEcCtD
Canagliflozin—Nervous system disorder—Quinine—malaria	0.000663	0.00344	CcSEcCtD
Canagliflozin—Loss of consciousness—Quinidine barbiturate—malaria	0.000657	0.00341	CcSEcCtD
Canagliflozin—Skin disorder—Quinidine—malaria	0.000656	0.00341	CcSEcCtD
Canagliflozin—Skin disorder—Quinine—malaria	0.000656	0.00341	CcSEcCtD
Canagliflozin—Pruritus—Sulfadiazine—malaria	0.000654	0.0034	CcSEcCtD
Canagliflozin—Convulsion—Quinidine barbiturate—malaria	0.000647	0.00336	CcSEcCtD
Canagliflozin—Convulsion—Pentoxifylline—malaria	0.000646	0.00335	CcSEcCtD
Canagliflozin—Hypotension—Clindamycin—malaria	0.000644	0.00334	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000632	0.00328	CcSEcCtD
Canagliflozin—Hypotension—Quinidine—malaria	0.000631	0.00328	CcSEcCtD
Canagliflozin—Hypotension—Quinine—malaria	0.000631	0.00328	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000631	0.00327	CcSEcCtD
Canagliflozin—ABCB1—kidney—malaria	0.000621	0.00651	CbGeAlD
Canagliflozin—Dry mouth—Pentoxifylline—malaria	0.000621	0.00322	CcSEcCtD
Canagliflozin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HBB—malaria	0.000614	0.0173	CbGpPWpGaD
Canagliflozin—UGT2B4—Biological oxidations—HPGDS—malaria	0.000609	0.0171	CbGpPWpGaD
Canagliflozin—Infection—Pentoxifylline—malaria	0.000605	0.00314	CcSEcCtD
Canagliflozin—Shock—Quinidine barbiturate—malaria	0.0006	0.00311	CcSEcCtD
Canagliflozin—Shock—Pentoxifylline—malaria	0.000599	0.00311	CcSEcCtD
Canagliflozin—Nervous system disorder—Quinidine barbiturate—malaria	0.000598	0.0031	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Clindamycin—malaria	0.000595	0.00309	CcSEcCtD
Canagliflozin—Fatigue—Clindamycin—malaria	0.000594	0.00308	CcSEcCtD
Canagliflozin—Skin disorder—Quinidine barbiturate—malaria	0.000592	0.00307	CcSEcCtD
Canagliflozin—Skin disorder—Pentoxifylline—malaria	0.000591	0.00307	CcSEcCtD
Canagliflozin—Constipation—Clindamycin—malaria	0.000589	0.00306	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Quinine—malaria	0.000583	0.00303	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Quinidine—malaria	0.000583	0.00303	CcSEcCtD
Canagliflozin—Rash—Sulfadiazine—malaria	0.000583	0.00303	CcSEcCtD
Canagliflozin—Dermatitis—Sulfadiazine—malaria	0.000583	0.00302	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Dapsone—malaria	0.000582	0.00302	CcSEcCtD
Canagliflozin—Hypotension—Quinidine barbiturate—malaria	0.00057	0.00296	CcSEcCtD
Canagliflozin—Hypotension—Pentoxifylline—malaria	0.000569	0.00295	CcSEcCtD
Canagliflozin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HP—malaria	0.000566	0.0159	CbGpPWpGaD
Canagliflozin—Gastrointestinal pain—Clindamycin—malaria	0.000563	0.00292	CcSEcCtD
Canagliflozin—Abdominal pain—Dapsone—malaria	0.000563	0.00292	CcSEcCtD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC4A1—malaria	0.000559	0.0157	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC4A1—malaria	0.000559	0.0157	CbGpPWpGaD
Canagliflozin—CYP3A4—liver—malaria	0.000555	0.00581	CbGeAlD
Canagliflozin—Gastrointestinal pain—Quinine—malaria	0.000553	0.00287	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Quinidine—malaria	0.000553	0.00287	CcSEcCtD
Canagliflozin—Nausea—Sulfadiazine—malaria	0.000549	0.00285	CcSEcCtD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000547	0.0154	CbGpPWpGaD
Canagliflozin—Urticaria—Clindamycin—malaria	0.000547	0.00284	CcSEcCtD
Canagliflozin—Abdominal pain—Clindamycin—malaria	0.000544	0.00283	CcSEcCtD
Canagliflozin—Urticaria—Quinine—malaria	0.000537	0.00279	CcSEcCtD
Canagliflozin—Urticaria—Quinidine—malaria	0.000537	0.00279	CcSEcCtD
Canagliflozin—Abdominal pain—Quinidine—malaria	0.000534	0.00277	CcSEcCtD
Canagliflozin—Abdominal pain—Quinine—malaria	0.000534	0.00277	CcSEcCtD
Canagliflozin—ABCB1—digestive system—malaria	0.000527	0.00552	CbGeAlD
Canagliflozin—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000526	0.00273	CcSEcCtD
Canagliflozin—Constipation—Quinidine barbiturate—malaria	0.000521	0.00271	CcSEcCtD
Canagliflozin—Constipation—Pentoxifylline—malaria	0.000521	0.0027	CcSEcCtD
Canagliflozin—ALB—FOXA2 and FOXA3 transcription factor networks—PKLR—malaria	0.000517	0.0145	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—HBB—malaria	0.000515	0.0145	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Clindamycin—malaria	0.000507	0.00263	CcSEcCtD
Canagliflozin—ABCB1—blood—malaria	0.000502	0.00526	CbGeAlD
Canagliflozin—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000499	0.00259	CcSEcCtD
Canagliflozin—Hypersensitivity—Quinidine—malaria	0.000498	0.00258	CcSEcCtD
Canagliflozin—Hypersensitivity—Quinine—malaria	0.000498	0.00258	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Pentoxifylline—malaria	0.000498	0.00258	CcSEcCtD
Canagliflozin—Asthenia—Clindamycin—malaria	0.000494	0.00256	CcSEcCtD
Canagliflozin—Pruritus—Clindamycin—malaria	0.000487	0.00253	CcSEcCtD
Canagliflozin—ABCB1—bone marrow—malaria	0.000486	0.00509	CbGeAlD
Canagliflozin—Asthenia—Quinidine—malaria	0.000485	0.00252	CcSEcCtD
Canagliflozin—Asthenia—Quinine—malaria	0.000485	0.00252	CcSEcCtD
Canagliflozin—Urticaria—Quinidine barbiturate—malaria	0.000484	0.00251	CcSEcCtD
Canagliflozin—Urticaria—Pentoxifylline—malaria	0.000484	0.00251	CcSEcCtD
Canagliflozin—Abdominal pain—Quinidine barbiturate—malaria	0.000482	0.0025	CcSEcCtD
Canagliflozin—Abdominal pain—Pentoxifylline—malaria	0.000481	0.0025	CcSEcCtD
Canagliflozin—Pruritus—Quinine—malaria	0.000478	0.00248	CcSEcCtD
Canagliflozin—Pruritus—Quinidine—malaria	0.000478	0.00248	CcSEcCtD
Canagliflozin—Dizziness—Clindamycin—malaria	0.000455	0.00236	CcSEcCtD
Canagliflozin—Hypersensitivity—Quinidine barbiturate—malaria	0.000449	0.00233	CcSEcCtD
Canagliflozin—Hypersensitivity—Pentoxifylline—malaria	0.000448	0.00233	CcSEcCtD
Canagliflozin—Dizziness—Quinidine—malaria	0.000447	0.00232	CcSEcCtD
Canagliflozin—Dizziness—Quinine—malaria	0.000447	0.00232	CcSEcCtD
Canagliflozin—ALB—Lipoprotein metabolism—SCARB1—malaria	0.000438	0.0123	CbGpPWpGaD
Canagliflozin—Asthenia—Quinidine barbiturate—malaria	0.000438	0.00227	CcSEcCtD
Canagliflozin—Asthenia—Pentoxifylline—malaria	0.000437	0.00227	CcSEcCtD
Canagliflozin—Rash—Clindamycin—malaria	0.000434	0.00225	CcSEcCtD
Canagliflozin—Dermatitis—Clindamycin—malaria	0.000434	0.00225	CcSEcCtD
Canagliflozin—Pruritus—Quinidine barbiturate—malaria	0.000431	0.00224	CcSEcCtD
Canagliflozin—Pruritus—Pentoxifylline—malaria	0.000431	0.00223	CcSEcCtD
Canagliflozin—Rash—Quinine—malaria	0.000426	0.00221	CcSEcCtD
Canagliflozin—Rash—Quinidine—malaria	0.000426	0.00221	CcSEcCtD
Canagliflozin—Dermatitis—Quinine—malaria	0.000426	0.00221	CcSEcCtD
Canagliflozin—Dermatitis—Quinidine—malaria	0.000426	0.00221	CcSEcCtD
Canagliflozin—Nausea—Dapsone—malaria	0.000423	0.00219	CcSEcCtD
Canagliflozin—ALB—Folate Metabolism—HBB—malaria	0.000419	0.0118	CbGpPWpGaD
Canagliflozin—Nausea—Clindamycin—malaria	0.000409	0.00212	CcSEcCtD
Canagliflozin—Dizziness—Quinidine barbiturate—malaria	0.000403	0.00209	CcSEcCtD
Canagliflozin—Dizziness—Pentoxifylline—malaria	0.000403	0.00209	CcSEcCtD
Canagliflozin—Nausea—Quinidine—malaria	0.000401	0.00208	CcSEcCtD
Canagliflozin—Nausea—Quinine—malaria	0.000401	0.00208	CcSEcCtD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.000397	0.0112	CbGpPWpGaD
Canagliflozin—ABCB1—liver—malaria	0.000393	0.00411	CbGeAlD
Canagliflozin—UGT1A9—Phase II conjugation—HPGDS—malaria	0.000385	0.0108	CbGpPWpGaD
Canagliflozin—Rash—Quinidine barbiturate—malaria	0.000384	0.002	CcSEcCtD
Canagliflozin—Dermatitis—Quinidine barbiturate—malaria	0.000384	0.00199	CcSEcCtD
Canagliflozin—Rash—Pentoxifylline—malaria	0.000384	0.00199	CcSEcCtD
Canagliflozin—Dermatitis—Pentoxifylline—malaria	0.000383	0.00199	CcSEcCtD
Canagliflozin—Nausea—Quinidine barbiturate—malaria	0.000362	0.00188	CcSEcCtD
Canagliflozin—Nausea—Pentoxifylline—malaria	0.000362	0.00188	CcSEcCtD
Canagliflozin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCARB1—malaria	0.000341	0.0096	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—G6PD—malaria	0.000337	0.00948	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—HBB—malaria	0.000333	0.00937	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—G6PD—malaria	0.000329	0.00925	CbGpPWpGaD
Canagliflozin—ABCB1—brain—malaria	0.000312	0.00326	CbGeAlD
Canagliflozin—SLC5A1—Metabolism—DHODH—malaria	0.000308	0.00866	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—DHODH—malaria	0.000308	0.00866	CbGpPWpGaD
Canagliflozin—ALB—Lipid and lipoprotein metabolism—SCARB1—malaria	0.000291	0.00819	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—SCARB1—malaria	0.000287	0.00806	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—SLC4A1—malaria	0.000262	0.00737	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—SLC4A1—malaria	0.000262	0.00737	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—DECR1—malaria	0.000246	0.00693	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—DECR1—malaria	0.000246	0.00693	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—DHODH—malaria	0.000238	0.00669	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PKLR—malaria	0.000237	0.00667	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PKLR—malaria	0.000237	0.00667	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—DHFR—malaria	0.000236	0.00663	CbGpPWpGaD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000235	0.00662	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—SCARB1—malaria	0.000233	0.00656	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—HPGDS—malaria	0.000225	0.00634	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—HBB—malaria	0.000223	0.00626	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—HBB—malaria	0.000223	0.00626	CbGpPWpGaD
Canagliflozin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—malaria	0.000214	0.00602	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—G6PD—malaria	0.000211	0.00594	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—G6PD—malaria	0.000211	0.00594	CbGpPWpGaD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.00021	0.0059	CbGpPWpGaD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000209	0.00588	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—SLC4A1—malaria	0.000202	0.00569	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PKLR—malaria	0.000199	0.00558	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PKLR—malaria	0.000199	0.00558	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—DECR1—malaria	0.00019	0.00535	CbGpPWpGaD
Canagliflozin—UGT1A9—PPARA activates gene expression—CD36—malaria	0.000186	0.00522	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—SCARB1—malaria	0.000185	0.00521	CbGpPWpGaD
Canagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	0.000182	0.00511	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—G6PD—malaria	0.000177	0.00498	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—G6PD—malaria	0.000177	0.00498	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—HBB—malaria	0.000172	0.00484	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000165	0.00463	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL12B—malaria	0.000163	0.00458	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—CRP—malaria	0.000162	0.00456	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000158	0.00444	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC4A1—malaria	0.000156	0.00438	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PKLR—malaria	0.000153	0.00431	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL4—malaria	0.000153	0.00429	CbGpPWpGaD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000152	0.00428	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—DHFR—malaria	0.000149	0.0042	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—DHFR—malaria	0.000149	0.0042	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—ICAM1—malaria	0.000149	0.00419	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—G6PD—malaria	0.000137	0.00384	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—HPGDS—malaria	0.000135	0.00379	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—HPGDS—malaria	0.000135	0.00379	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—CRP—malaria	0.000132	0.00371	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—CD36—malaria	0.000125	0.00353	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	0.000125	0.00352	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—DHFR—malaria	0.000125	0.00352	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—DHFR—malaria	0.000125	0.00352	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—SCARB1—malaria	0.000124	0.00348	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—SCARB1—malaria	0.000124	0.00348	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—ICAM1—malaria	0.000121	0.00341	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—CD36—malaria	0.00012	0.00336	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—CD40LG—malaria	0.000119	0.00335	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL10—malaria	0.000119	0.00335	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL4—malaria	0.000116	0.00326	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IFNG—malaria	0.000113	0.00319	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—HLA-B—malaria	0.000113	0.00319	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—FAS—malaria	0.000107	0.003	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	0.000105	0.00296	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—CRP—malaria	0.000105	0.00295	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—HPGDS—malaria	0.000104	0.00293	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IL1B—malaria	0.000101	0.00284	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—DHFR—malaria	9.67e-05	0.00272	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—ICAM1—malaria	9.63e-05	0.00271	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—SCARB1—malaria	9.57e-05	0.00269	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	9.51e-05	0.00267	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IFNG—malaria	9.23e-05	0.00259	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—DHODH—malaria	8.8e-05	0.00248	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—malaria	8.66e-05	0.00243	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC4A1—malaria	8.37e-05	0.00235	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—DECR1—malaria	8.27e-05	0.00233	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL1B—malaria	8.23e-05	0.00231	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—HBB—malaria	8.22e-05	0.00231	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL2—malaria	8.2e-05	0.00231	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—SCARB1—malaria	7.95e-05	0.00224	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CD36—malaria	7.78e-05	0.00219	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—CD36—malaria	7.78e-05	0.00219	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—NOS2—malaria	7.63e-05	0.00215	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—NOS2—malaria	7.63e-05	0.00215	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SLC4A1—malaria	7.49e-05	0.0021	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—TNF—malaria	7.34e-05	0.00206	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	7.33e-05	0.00206	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IFNG—malaria	7.33e-05	0.00206	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—DECR1—malaria	7.04e-05	0.00198	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IFNG—malaria	7e-05	0.00197	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL1B—malaria	6.54e-05	0.00184	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—HPGDS—malaria	6.37e-05	0.00179	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—HBB—malaria	6.36e-05	0.00179	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL1B—malaria	6.25e-05	0.00176	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL2—malaria	6.22e-05	0.00175	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CD36—malaria	6e-05	0.00169	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TNF—malaria	5.97e-05	0.00168	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IL6—malaria	5.92e-05	0.00167	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PKLR—malaria	5.67e-05	0.0016	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—CD4—malaria	5.65e-05	0.00159	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—CD4—malaria	5.65e-05	0.00159	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—CD36—malaria	5.57e-05	0.00157	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	5.27e-05	0.00148	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—G6PD—malaria	5.06e-05	0.00142	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CD36—malaria	4.99e-05	0.0014	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL6—malaria	4.82e-05	0.00136	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—TNF—malaria	4.74e-05	0.00133	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—DHODH—malaria	4.61e-05	0.0013	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.53e-05	0.00127	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TNF—malaria	4.53e-05	0.00127	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.16e-05	0.00117	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—DHODH—malaria	4.04e-05	0.00114	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SLC4A1—malaria	3.92e-05	0.0011	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—HPGDS—malaria	3.86e-05	0.00108	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL6—malaria	3.83e-05	0.00108	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—DECR1—malaria	3.68e-05	0.00104	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—DHFR—malaria	3.58e-05	0.00101	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SCARB1—malaria	3.54e-05	0.000996	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SLC4A1—malaria	3.43e-05	0.000966	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—HBB—malaria	3.33e-05	0.000937	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—DECR1—malaria	3.23e-05	0.000908	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—IL2—malaria	3.12e-05	0.000877	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—IL6—malaria	3.06e-05	0.00086	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—IL6—malaria	3.06e-05	0.00086	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PKLR—malaria	2.97e-05	0.000835	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—HBB—malaria	2.92e-05	0.000821	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—CD36—malaria	2.87e-05	0.000807	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—G6PD—malaria	2.65e-05	0.000744	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	2.61e-05	0.000735	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PKLR—malaria	2.6e-05	0.000732	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—DHODH—malaria	2.49e-05	0.0007	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—NOS2—malaria	2.36e-05	0.000663	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—G6PD—malaria	2.32e-05	0.000652	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.24e-05	0.000629	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CD36—malaria	2.22e-05	0.000625	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SLC4A1—malaria	2.12e-05	0.000595	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—HPGDS—malaria	2.02e-05	0.000568	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—DECR1—malaria	1.99e-05	0.000559	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—DHFR—malaria	1.87e-05	0.000527	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SCARB1—malaria	1.85e-05	0.000521	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HBB—malaria	1.8e-05	0.000506	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—HPGDS—malaria	1.77e-05	0.000497	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—DHFR—malaria	1.64e-05	0.000461	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SCARB1—malaria	1.62e-05	0.000457	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IL2—malaria	1.61e-05	0.000452	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PKLR—malaria	1.6e-05	0.000451	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—G6PD—malaria	1.43e-05	0.000402	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CD36—malaria	1.16e-05	0.000327	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HPGDS—malaria	1.09e-05	0.000306	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CD36—malaria	1.02e-05	0.000287	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—DHFR—malaria	1.01e-05	0.000284	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SCARB1—malaria	1e-05	0.000281	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CD36—malaria	6.28e-06	0.000177	CbGpPWpGaD
